TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33169493

Group type: EXPERIMENTAL
Intervention: Chronic sleep restriction (5-hr time in bed for 5 nights)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Acute sleep deprivation (38 hours after 1 night of recovery sleep with 8-hr TIB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (8-hr time in bed for 5 nights)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Recovery sleep (10-hr TIB) after acute sleep deprivation
Number of subjects: 36
Study: 32407827

Group type: EXPERIMENTAL
Intervention: Reflective practice intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Video alone
Number of subjects: 0
Study: 35510486

Group type: EXPERIMENTAL
Intervention: Imetelstat 9.4 mg/kg administered as an intravenous infusion every 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best available therapy, excluding JAK inhibitors
Number of subjects: 0
Study: 33243811

Group type: EXPERIMENTAL
Intervention: Individualised physical exercise training programmes combined with increased protein intake (IPET+P) receiving 27.5 g protein/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care with protein supplementation (UC+P) receiving 27.5 g protein/day
Number of subjects: 0
Study: 36037324

Group type: EXPERIMENTAL
Intervention: Mindfulness-based emotion management intervention (80 minutes, once per week for 4 weeks)
Number of subjects: 72
Study: 32744354

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg or 25mg
Number of subjects: 6152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6152
Study: 36658596

Group type: EXPERIMENTAL
Intervention: LessStress prevention training programme (90 minutes duration)
Number of subjects: 1894

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1894
Study: 34207231

Group type: EXPERIMENTAL
Intervention: Nutritional education intervention with follow-up session one year later
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study: 35703114

Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 1 year
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 3 years
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 5 years
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Risk factor - Male sex
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Risk factor - Diabetes mellitus at/before diagnosis of ICP
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Risk factor - Aged less than 18 years at onset of ICP
Number of subjects: 1633
Study: 32113823

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pioglitazone
Number of subjects: 60
Study: 35780048

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus radical local therapy (RLT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 200
Study: 35109568

Group type: EXPERIMENTAL
Intervention: Healthy Patterns intervention
Number of subjects: 170
Study: 36367426

Group type: EXPERIMENTAL
Intervention: Brief Motivational Interview
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group Problem Solving
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard of care (OSHA safety cards)
Number of subjects: 75
Study: 36227238

Group type: EXPERIMENTAL
Intervention: Self-Selected Music (SSM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 17
Study: 36375189

Group type: EXPERIMENTAL
Intervention: Transforaminal endoscopic lumbar discectomy (TELD)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Interlaminar endoscopic lumbar discectomy (IELD)
Number of subjects: 91
Study: 33016711

Group type: EXPERIMENTAL
Intervention: Kernel machine operating on data grouped into equally labeled subsets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Margin classifiers with randomly labeled data
Number of subjects: 0
Study: 35190177

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg intravenously on days 1, 15, and 29; n = 23)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nivolumab with ipilimumab (1 mg/kg intravenously on day 1; n = 21)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nivolumab or Nivolumab with ipilimumab
Number of subjects: 44
Study: 34702332

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (post‐tetanic count 1‐2 twitches)
Number of subjects: 922

Group type: COMPARATOR
Intervention: Standard care (single‐dose muscle relaxant administration at induction)
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block
Number of subjects: 922
Study: 33652495

Group type: EXPERIMENTAL
Intervention: 25G Franseen needle
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 22G Franseen needle
Number of subjects: 140
Study: 32886321

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs) - Dabigatran (66%), Apixaban (21%), Rivaroxaban (13%); 58% prescribed reduced dose.
Number of subjects: 566
Study: 33586606

Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 32603357

Group type: EXPERIMENTAL
Intervention: P-sha (novel needle guide)
Number of subjects: 35

Group type: COMPARATOR
Intervention: P-com (commercial needle guide)
Number of subjects: 35

Group type: COMPARATOR
Intervention: P-free (free-hand placement)
Number of subjects: 35
Study: 35562830

Group type: EXPERIMENTAL
Intervention: Meridian theory-based extracorporeal shock wave therapy (ESWT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional extracorporeal shock wave therapy (ESWT)
Number of subjects: 66
Study: 34168037

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 824

Group type: COMPARATOR
Intervention: In vitro fertilisation (IVF)
Number of subjects: 824
Study: 32907352

Group type: EXPERIMENTAL
Intervention: 5% patchouli oil in sweet almond oil (patchouli group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pure sweet almond oil (control group)
Number of subjects: 50
Study: 34053097

Group type: EXPERIMENTAL
Intervention: Virtual reality glasses for distraction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no distraction)
Number of subjects: 100
Study: 33490019

Group type: COMPARATOR
Intervention: Low education level
Number of subjects: 37922

Group type: COMPARATOR
Intervention: Per capita monthly income
Number of subjects: 37922

Group type: COMPARATOR
Intervention: Low education level and physical activity (PA) interaction
Number of subjects: 37922
Study: 35648204

Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 36
Study: 33676295

Group type: EXPERIMENTAL
Intervention: CMS classification
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: CRCA classification
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI treatment
Number of subjects: 679
Study: 35588050

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously every 4 weeks for 6 cycles
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel 125 mg/m2 weekly for 12 weeks
Number of subjects: 780

Group type: COMPARATOR
Intervention: Nab-paclitaxel days 1 and 8 every 3 weeks for 4 cycles (8 doses)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Denosumab (with or without)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel weekly
Number of subjects: 780
Study: 33298509

Group type: EXPERIMENTAL
Intervention: Matrix2 coils
Number of subjects: 626

Group type: COMPARATOR
Intervention: Bare metal coils (BMCs)
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Unruptured aneurysms
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Ruptured aneurysms
Number of subjects: 626
Study: 34448342

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tackers
Number of subjects: 60
Study: 32581121

Group type: EXPERIMENTAL
Intervention: Individual Empowerment narrative
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Community Empowerment narrative
Number of subjects: 565

Group type: COMPARATOR
Intervention: Poverty Alleviation narrative
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Local forecasting methodology
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Narrative most effective for recipients
Number of subjects: 565
Study: 32223963

Group type: EXPERIMENTAL
Intervention: Low frequency ventilation (LFV) during CPB
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lungs left collapsed during CPB
Number of subjects: 37
Study: 35960902

Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice a day orally
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 40
Study: 33880833

Group type: EXPERIMENTAL
Intervention: Nomogram composed of preoperative variables
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Nomogram validation
Number of subjects: 999
Study: 32316331

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Manual therapy group
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 35190371

Group type: EXPERIMENTAL
Intervention: Urinary collection devices (UCDs)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Provision of clear information
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sharing of information derived from uncontaminated samples
Number of subjects: 29
Study: 34154627

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35657133

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF)
Number of subjects: 793

Group type: COMPARATOR
Intervention: Elbasvir/Grazoprevir (EBR/GZR)
Number of subjects: 793
Study: 32646561

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg every 2 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 69
Study: 36203323

Group type: EXPERIMENTAL
Intervention: Active cTBS treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham cTBS treatment
Number of subjects: 54
Study: 33269455

Group type: EXPERIMENTAL
Intervention: Osteogenic protein-1 (OP-1)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 41
Study: 35963797

Group type: EXPERIMENTAL
Intervention: Nurse led triage intervention
Number of subjects: 0
Study: 36250353

Group type: EXPERIMENTAL
Intervention: Sad faces gazing upwards
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad faces gazing downwards
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Environmental frame of reference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Happy faces
Number of subjects: 0
Study: 32096437

Group type: EXPERIMENTAL
Intervention: Manually corrected wild-type and perL mutant songs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lomb-Scargle (L-S) periodogram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization of locomotor and song data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other time-series analyses
Number of subjects: 0
Study: 34860705

Group type: EXPERIMENTAL
Intervention: Naringenin supplementation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32297539

Group type: EXPERIMENTAL
Intervention: Bayesian methods for pilot studies
Number of subjects: 0
Study: 36108849

Group type: EXPERIMENTAL
Intervention: SPORTS group (2000 m jogging in 20 min for 3 times in 4 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: CON group (no intervention)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: SPORTS group
Number of subjects: 55
Study: 33597147

Group type: EXPERIMENTAL
Intervention: KeepWell (eHealth self-management application)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (survey platform)
Number of subjects: 0
Study: 32162607

Group type: EXPERIMENTAL
Intervention: Mg citrate (MgC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mg oxide (MgO)
Number of subjects: 14
Study: 36204953

Group type: EXPERIMENTAL
Intervention: 3D‐DSD combined with double positioning crown extension guide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional aesthetic crown lengthening and full crown restoration
Number of subjects: 20
Study: 33907188

Group type: EXPERIMENTAL
Intervention: Duloxetine (serotonin and noradrenaline reuptake inhibitor)
Number of subjects: 4647
Study: 32198104

Group type: EXPERIMENTAL
Intervention: Patient-Only intervention
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Patient+Partner intervention
Number of subjects: 105
Study: 34910143

Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA‐IM)
Number of subjects: 4062

Group type: EXPERIMENTAL
Intervention: Copper Intrauterine Device (IUD)
Number of subjects: 4062

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) Implant
Number of subjects: 4062

Group type: COMPARATOR
Intervention: DMPA‐IM
Number of subjects: 4062

Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 4062

Group type: EXPERIMENTAL
Intervention: HIV acquisition
Number of subjects: 4062
Study: 34222059

Group type: COMPARATOR
Intervention: Mindfulness and placebo
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: VD (Vitamin D)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Mindfulness and VD (Vitamin D)
Number of subjects: 225
Study: 35285287

Group type: EXPERIMENTAL
Intervention: Individualized approach by clinicians
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Adaptations in practice
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Recognition of autism features
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Training on autism adaptations
Number of subjects: 16
Study: 32530340

Group type: EXPERIMENTAL
Intervention: Skin adhesive
Number of subjects: 121

Group type: COMPARATOR
Intervention: Conventional suture
Number of subjects: 121
Study: 32868130

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34802887

Group type: EXPERIMENTAL
Intervention: Pre-operative removal of third molars 6 months prior to BSSO
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intra-operative removal of contralateral third molars during BSSO
Number of subjects: 75
Study: 33928827

Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined oral contraceptives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone therapy and combined oral contraceptives
Number of subjects: 0
Study: 33112264

Group type: EXPERIMENTAL
Intervention: Diagnostic models developed using supervised machine learning algorithms and regression models.
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: 19-point score system for stratifying patients according to subtype diagnosis.
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Flow-chart integrating the score system.
Number of subjects: 158
Study: 35166800

Group type: COMPARATOR
Intervention: Care Management (n = 6230)
Number of subjects: 18644

Group type: COMPARATOR
Intervention: Skills Training (n = 6227)
Number of subjects: 18644

Group type: COMPARATOR
Intervention: Usual Care (n = 6187)
Number of subjects: 18644

Group type: COMPARATOR
Intervention: Care Management vs Usual Care
Number of subjects: 18644

Group type: COMPARATOR
Intervention: Skills Training vs Usual Care
Number of subjects: 18644
Study: 34139220

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg of body mass)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 32384500

Group type: COMPARATOR
Intervention: 1 dose of intravenous dexamethasone and 1 dose of normal saline (Group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 2 doses of intravenous dexamethasone (Group B)
Number of subjects: 200
Study: 36562419

Group type: EXPERIMENTAL
Intervention: Low-dose fenfluramine
Number of subjects: 10
Study: 33630218

Group type: EXPERIMENTAL
Intervention: Liver volume index
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Nomogram-based prediction score from liver cirrhosis, gamma-glutamyl transferase, and liver volume index
Number of subjects: 277
Study: 32627243

Group type: EXPERIMENTAL
Intervention: Pain-related TMD group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Mixed TMD group
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intra-articular TMD group
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study: 35113921

Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (ETAU)
Number of subjects: 148
Study: 34074895

Group type: EXPERIMENTAL
Intervention: Pre-TAVI assessment of the septo-valvular angle (SVA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Measurement of the septo-valvular angle (SVA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Measurement of the muscular septum length (MSL)
Number of subjects: 57
Study: 35196580

Group type: EXPERIMENTAL
Intervention: Heating therapy
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (no heating therapy)
Number of subjects: 145
Study: 33170576

Group type: EXPERIMENTAL
Intervention: Reheart compression assist device
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional method without Reheart
Number of subjects: 32
Study: 35649607

Group type: EXPERIMENTAL
Intervention: Make It Training - Mindfulness-Based and Skills-Based Distress Reduction
Number of subjects: 600

Group type: COMPARATOR
Intervention: Treatment as Usual Optimised (TAU-O)
Number of subjects: 600
Study: 33448754

Group type: EXPERIMENTAL
Intervention: Resistance Exercise Group (REG) - performed progressive resistance exercises with elastic bands (24 sessions over 12 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control Group (CG) - only had their symptoms monitored through phone calls, maintaining usual care treatment
Number of subjects: 31
Study: 33151780

Group type: EXPERIMENTAL
Intervention: Lithium Disilicate (IPS e.max Press) with 4.5 mm occlusal thickness and 2 mm radicular extension
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lithium Disilicate (IPS e.max Press) with 4.5 mm occlusal thickness
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High translucency zirconia (Ceramill Zolid HT) with conventional 2 mm thickness
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Polymer infiltrated ceramic (Vita Enamic)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lithium Disilicate and Polymer infiltrated ceramic
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High translucency zirconia with 2 mm radicular extension
Number of subjects: 90
Study: 35715806

Group type: EXPERIMENTAL
Intervention: Self-monitoring toolkit implementation
Number of subjects: 0
Study: 33196633

Group type: EXPERIMENTAL
Intervention: Pushing down on the chest wall during defibrillation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pushing down on the chest wall during cardioversion
Number of subjects: 3
Study: 35287480

Group type: EXPERIMENTAL
Intervention: Yangxin Recipe (YXR) + conventional western medicine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 78
Study: 32297357

Group type: EXPERIMENTAL
Intervention: Ultrasensitive ultrasound microvessel imaging (UMI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional color flow imaging (CFI)
Number of subjects: 48
Study: 35691324

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 (AZD1222) vaccine, 5 × 10^10 viral particles, two doses
Number of subjects: 262

Group type: COMPARATOR
Intervention: Capsular group B meningococcal vaccine (control)
Number of subjects: 262
Study: 35556001

Group type: EXPERIMENTAL
Intervention: PB125 (100mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34308899

Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy (CT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Proprioception exercises (PE)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combined CT and PE (CT&PE)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 89
Study: 33965295

Group type: EXPERIMENTAL
Intervention: Variable-angle volar locking plate (VAVLP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fixed-angle volar locking plate (FAVLP)
Number of subjects: 120
Study: 33934714

Group type: EXPERIMENTAL
Intervention: Levetiracetam (1000–3000 mg)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Fosphenytoin (22.5 mg/kg)
Number of subjects: 176
Study: 32156580

Group type: EXPERIMENTAL
Intervention: Occupation-based intervention including physical exercises (OBI)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Physical exercise-based occupation-focused intervention
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Patients with weak SOC
Number of subjects: 504
Study: 35149145

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham feedback (Control)
Number of subjects: 36
Study: 34052232

Group type: EXPERIMENTAL
Intervention: IV sildenafil (loading: 0.1 mg/kg over 30 minutes; maintenance: 0.03 mg/kg/h)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: IV sildenafil
Number of subjects: 59
Study: 33926584

Group type: EXPERIMENTAL
Intervention: Verbal learning and memory (vLM)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Processing speed-cognitive flexibility (PSCF)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 349
Study: 32240542

Group type: EXPERIMENTAL
Intervention: Mobile text messaging (3 to 5 messages daily for one month)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no messages)
Number of subjects: 128
Study: 36197388

Group type: EXPERIMENTAL
Intervention: Drug use prevention program #TamoJunto2.0
Number of subjects: 5213

Group type: EXPERIMENTAL
Intervention: Marijuana use
Number of subjects: 5213

Group type: EXPERIMENTAL
Intervention: Being a girl
Number of subjects: 5213

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 5213